Hacker News new | ask | show | jobs
by legitster 847 days ago
That could very well be! There's not any research I can find that says "people with access to epipens die at X rate and people without die Y rate" so we have to take the manufacturer's claims at face value.

Regardless of how we are achieving it, it's just something where my perceived overall risk was much higher than the actual data justified.